Literature DB >> 23106944

Judith Graham Pool and the discovery of cryoprecipitate.

C K Kasper1.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 23106944     DOI: 10.1111/hae.12042

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  7 in total

Review 1.  Current and emerging factor VIII replacement products for hemophilia A.

Authors:  Lorraine A Cafuir; Christine L Kempton
Journal:  Ther Adv Hematol       Date:  2017-08-26

Review 2.  Pediatric Fibrinogen PART I-Pitfalls in Fibrinogen Evaluation and Use of Fibrinogen Replacement Products in Children.

Authors:  Elise J Huisman; Gemma Louise Crighton
Journal:  Front Pediatr       Date:  2021-04-21       Impact factor: 3.418

Review 3.  The Need for Comprehensive Care for Persons with Chronic Immune Thrombocytopenic Purpura.

Authors:  Kristin T Ansteatt; Chanel J Unzicker; Marsha L Hurn; Oluwaseun O Olaiya; Diane J Nugent; Michael D Tarantino
Journal:  J Blood Med       Date:  2020-12-17

Review 4.  Advances of adeno-associated virus applied in gene therapy to hemophilia from bench work to the clinical use.

Authors:  Xiaolei Pei; Mingzhe Han; Lei Zhang
Journal:  Blood Sci       Date:  2019-10-21

Review 5.  Concizumab as a Subcutaneous Prophylactic Treatment Option for Patients with Hemophilia A or B: A Review of the Evidence and Patient's Perspectives.

Authors:  Samantha Pasca
Journal:  J Blood Med       Date:  2022-04-16

6.  Preparation and Storage of Cryoprecipitate Derived from Amotosalen and UVA-Treated Apheresis Plasma and Assessment of In Vitro Quality Parameters.

Authors:  Katarina Kovacic Krizanic; Florian Prüller; Konrad Rosskopf; Jean-Marc Payrat; Silke Andresen; Peter Schlenke
Journal:  Pathogens       Date:  2022-07-18

Review 7.  Cryoprecipitate therapy.

Authors:  B Nascimento; L T Goodnough; J H Levy
Journal:  Br J Anaesth       Date:  2014-06-27       Impact factor: 9.166

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.